These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12387034

  • 1. [Sulfonylurea and alpha-glucosidase inhibitor].
    Iijima T.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():459-63. PubMed ID: 12387034
    [No Abstract] [Full Text] [Related]

  • 2. [Combination therapy with sulfonylurea and alpha-glucosidase inhibitor].
    Iijima T.
    Nihon Rinsho; 1997 Nov; 55 Suppl():186-91. PubMed ID: 9434465
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Pharmacologic profile of oral antidiabetic agents].
    Okubo M, Yamane K, Kohno N.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011
    [No Abstract] [Full Text] [Related]

  • 5. [Alpha-glucosidase inhibitor and insulin sensitizer combination therapy in NIDDM].
    Kitaoka H.
    Nihon Rinsho; 1997 Nov; 55 Suppl():192-6. PubMed ID: 9434466
    [No Abstract] [Full Text] [Related]

  • 6. [Combination therapy with insulin and alpha-glucosidase inhibitor].
    Watanabe K, Kawamori R.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():447-51. PubMed ID: 12387032
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of voglibose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
    Nakamura J.
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():457-61. PubMed ID: 15779422
    [No Abstract] [Full Text] [Related]

  • 9. [Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)].
    Kawamori R, Kadowaki T, Ishida H.
    Nihon Rinsho; 2004 Apr; 62(4):831-9. PubMed ID: 15106356
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological treatment of type 2 diabetes.
    Hermans MP, Buysschaert M.
    Acta Clin Belg; 2004 Apr; 59(2):59-66. PubMed ID: 15224468
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action].
    Odaka H.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():393-8. PubMed ID: 12387024
    [No Abstract] [Full Text] [Related]

  • 17. Troglitazone combination therapy in obese type 2 diabetic patients poorly controlled with alpha-glucosidase inhibitors.
    Bando Y, Ushiogi Y, Okafuji K, Toya D, Tanaka N, Fujisawa M.
    J Int Med Res; 1999 Sep; 27(2):53-64. PubMed ID: 10446691
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of a very low dose of tolbutamide combined with an alpha-glucosidase inhibitor in non-insulin-dependent diabetes mellitus.
    Okada S, Ishii K, Hamada H, Tanokuchi S, Ichiki K, Ota Z.
    J Int Med Res; 1996 Sep; 24(5):433-7. PubMed ID: 8895047
    [Abstract] [Full Text] [Related]

  • 20. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
    Takamatsu J.
    Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.